Stock research

EMBC Embecta Corp.

Healthcare • Drug Manufacturers - Specialty & Generic

$3.66
-0.02 (—%)

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as...…

1Y change

-64.98%

Range high

$15.31

Congress · 90d

0

Insiders · 90d

0

Public signal layer

Who is disclosing activity in EMBC?

Latest linked filings in Indy

Congress

View all

No linked Congress trades yet.

Corporate insiders

View all

No insider transactions yet.

Price

Hover to inspect price

Showing 1Y history. Source: FMP historical price full.

Prev Close
$3.68
Day High
$3.70
Day Low
$3.58
52w High
$15.55
52w Low
$2.77
Volume
1,071,757
Avg Volume
Beta
0.807

* TTM/most recent where available

Company

Ticker
EMBC
Exchange
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
CEO
Devdatt Kurdikar
Employees
1850
Website
www.embecta.com

Key Metrics

Market Cap
217M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available

DCF Valuation

↓ Below DCF -91.0%

Standard DCF

$40.82 as of Jul. 30, 2026

Levered DCF

$28.67 as of Jul. 30, 2026

Market Price

$3.66 vs DCF -91.0%

DCF vs Price (30D window)

Price uses last 30 days; DCF line holds latest value across the window.

DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).